Clinical Trial: Circulating Oxytocin Changes in Response to MDMA vs. Placebo in Adult Patients With Autism Spectrum Disorder and Matched Healthy Controls

U.S., April 30 -- ClinicalTrials.gov registry received information related to the study (NCT07555132) titled 'Circulating Oxytocin Changes in Response to MDMA vs. Placebo in Adult Patients With Autism Spectrum Disorder and Matched Healthy Controls' on April 15.

Brief Summary: This study is to investigate the physiological mechanism of oxytocin system stimulation using 3,4-methylenedioxymethamphetamine (MDMA) as a physiological tool (acute oxytocin releases), not as a medication. This study seeks to test whether the oxytocin response after MDMA administration is different between individuals with autism spectrum disorder and matched healthy controls.

Study Start Date: June, 2026

Study Type: INTERVENTIONAL

Condition: Autism Spectrum Diso...